Plain-language summary
Published protocol for a systematic review of randomized controlled trials testing carnosine and related dipeptides against chronic disease risk markers, with prespecified outcomes spanning glycemia, lipid handling, and inflammation. Important context for interpreting later pooled analyses.
Key takeaways
- ›Establishes methodology for downstream evidence synthesis.
- ›Defines outcome priorities the field now uses.
- ›Anchors carnosine to chronic disease epidemiology.
About this summary
The summary and key takeaways above are written by our editorial team in plain language for general readers. They are not the original abstract. For the authors' own wording, methodology, statistics, and full reference list, follow the source link to the published record.